OBI Pharma (ROCO:4174) Long-Term Debt : NT$48.22 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is OBI Pharma Long-Term Debt?

OBI Pharma's Long-Term Debt for the quarter that ended in Dec. 2024 was NT$48.22 Mil.

OBI Pharma's quarterly Long-Term Debt increased from Jun. 2024 (NT$33.75 Mil) to Sep. 2024 (NT$56.74 Mil) but then declined from Sep. 2024 (NT$56.74 Mil) to Dec. 2024 (NT$48.22 Mil).

OBI Pharma's annual Long-Term Debt declined from Dec. 2022 (NT$21.00 Mil) to Dec. 2023 (NT$14.00 Mil) but then increased from Dec. 2023 (NT$14.00 Mil) to Dec. 2024 (NT$48.22 Mil).

OBI Pharma Long-Term Debt Historical Data

The historical data trend for OBI Pharma's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OBI Pharma Long-Term Debt Chart

OBI Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Debt

Get a 7-Day Free Trial

35.00

28.00

21.00

14.00

48.22

OBI Pharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Long-Term Debt	Get a 7-Day Free Trial															14.00	23.33	33.75	56.74	48.22

OBI Pharma (ROCO:4174) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

OBI Pharma Long-Term Debt Related Terms

Thank you for viewing the detailed overview of OBI Pharma's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

OBI Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OBI Pharma Inc (ROCO:4174) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 508, Section. 7, Zhongxiao East Road, 6th Floor, Nangang District, Taipei, TWN, 115011

Website

https://www.obipharma.com

OBI Pharma Inc is a clinical-stage oncology company. It focuses on research and development for cancer therapies and aims to develop ground-breaking drugs. The core value lies in its passion to develop and deliver a portfolio of antibody-drug conjugates (ADCs) drugs for patients, in addition to its Globo H active immunotherapy. Its portfolio includes a spectrum of cancer targets, such as TROP2, Nectin-4, HER2, and other potential targets. These ADCs are built based on two distinct ADC technology platforms, with different characteristics. It offers a plug-and-play advantage through a specialized site-specific conjugation using a proprietary enzyme. Its segments are the anti-cancer new drug; bispecific monoclonal antibody new drug; botulinum toxin new drug; and CDMO segment.

OBI Pharma Headlines

No Headlines